SCM Pharma makes an appointment

Paul Thomas joins CDMO as a non-executive director

Paul Thomas

SCM Pharma, a specialist contract development and manufacturing organisation (CDMO), has appointed a new director to bolster its senior team’s expertise and support its ongoing expansion.

Qualified Person (QP) Paul Thomas has joined the UK-based company as a non-executive director and brings a wealth of sterile manufacturing, technical and commercial experience gained over 25 years in the sector working for companies such as Warner Lambert, Penn Pharma and Nycomed Amersham (now GE).

A trained chemist and QP, Thomas has worked across many aspects of drug development and manufacturing during his career including analytical, production, quality and senior commercial roles across the world.